8290%
Subscribers on Youtube.

Sign up to access historical data

Sign up

Month over Month

Subscribers on Youtube.

Oct 2024 829
Sep 2024 827
Aug 2024 821

How many users are subscribing to Apellis Pharmaceuticals on Youtube?

Apellis Pharmaceuticals has 829 subscribers on Youtube.

Analyzing Youtube Subscribers, how is Apellis Pharmaceuticals performing compared to its industry peers?

Apellis Pharmaceuticals underperforms its industry peers when it comes to Youtube Subscribers, ranking in the 1st percentile.

How has Apellis Pharmaceuticals' Youtube Subscribers changed in the last month?

The subscriber base for Apellis Pharmaceuticals on YouTube has remained unchanged over the past month. While stability isn't negative, active growth on YouTube is often important for maintaining and enhancing brand visibility and engagement online.

Can the changes in Apellis Pharmaceuticals' YouTube subscriber base be linked to its overall brand influence and business success?

With a relatively small total of 829 YouTube subscribers, the impact of Apellis Pharmaceuticals' subscriber base on its brand influence and business performance is likely minimal. Significant growth or an increase in numbers would be essential for a meaningful impact.

Why is it important to monitor how many users are subscribing to Apellis Pharmaceuticals on Youtube?

A growing subscriber base signifies increasing audience engagement, brand strength, and a potential customer base, which is positive news for Apellis Pharmaceuticals. On the other hand, a declining number of YouTube subscribers can negatively impact a company's stock performance, signaling waning interest, decreased audience engagement, or a loss of market share. Therefore, monitoring YouTube subscribers is crucial for comprehending a company's online audience, gauging interest levels, and assessing customer perception, all of which can potentially influence the company's future trajectory and stock performance.

Sign up and get more insights on Apellis Pharmaceuticals and its Youtube subscribers.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.